Follow the Goldline Pharmaceutical share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €393.3m. The latest transaction was reported on 29 August 2026 (Acquisition). Among the most active insiders: Swapan Khandelwal. Every trade is openly available.
4
Insider Decl.
n/a
Thresholds
€24,065
4 ops.
Buy Volume
n/a
n/a
Sell Volume
23Σ signal
Buys €24,065n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,262 of 29,042 companies
72.7
score / 100
Value
72
Quality
74
FCF yld5.4%
Earn yld7.2%
EV/EBITDA8.5x
ROE34%
Gross mgn62%
Net mgn10%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.